JPRN-jRCT2080224807
已完成
1 期
Phase 1 trial of adrenomedullin: Multiple-dose administration study
niversity of MIyazaki0 个研究点目标入组 12 人2019年7月29日
概览
- 阶段
- 1 期
- 干预措施
- 未指定
- 疾病 / 适应症
- 未指定
- 发起方
- niversity of MIyazaki
- 入组人数
- 12
- 状态
- 已完成
- 最后更新
- 2年前
概览
简要总结
暂无简介。
研究者
入排标准
入选标准
- •healthy male
排除标准
- •history of malignancy and/or myocardial infarction
- •systolic blood pressure under 100 mmHg
- •pulse rate under 45 bpm
- •body weight over 90 kg
结局指标
主要结局
未指定
相似试验
已完成
1 期
Single-dose administration study of adrenomedulliJPRN-jRCT2080224808niversity of Miyazaki24
进行中（未招募）
1 期
A Multiple Ascending Dose Study of R1507 in Children and Adolescents With Advanced Solid TumorsEUCTR2016-001046-26-Outside-EU/EEAF. Hoffmann-La Roche AG58
进行中（未招募）
1 期
Clinical trial of chemotherapy combination cisplatin + fluorouracil with the novel targeted agent afatinib in patients with inoperable gastric cancerInoperable gastric and gastroesophageal junction cancerMedDRA version: 15.0Level: LLTClassification code 10017760Term: Gastric cancer NOSSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)Therapeutic area: Diseases [C] - Cancer [C04]EUCTR2011-006198-25-GRHellenic Cooperative Oncology Group55
招募中
不适用
A Phase I Multiple Ascending Dose (MAD) Study of RO5458640, a Humanized Monoclonal Antibody Against the TNF-like Weak Inducer of Apoptosis (TWEAK) Ligand, in Patients with Advanced Solid Cancersgeavanceerde en/of gemetastaseerde solide tumorencancersolid tumorsNL-OMON38050Roche Nederland B.V.20
进行中（未招募）
不适用
A double-blind, randomised, multiple dose, Phase III, multicentre study of Alpharadin in the treatment of patients with symptomatic hormone refractory prostate cancer with skeletal metastases. - Not ApplicableEUCTR2007-006195-11-SKAlgeta ASA900